Supporting equitable access to legal and regulated psychedelic medicine for all Canadians.

ABOUT OUR WORK

Working with partners in government, business, and the community, MAPS Canada is committed to advancing psychedelic medicine by supporting scientific, multidisciplinary research; advocating for drug policy reform; offering public education; and supporting equitable access to legal and regulated psychedelic medicine in Canada. 

LATEST AT MAPS CANADA

December 11, 2025

MAPS Canada presents:

Psychedelic Integration and Community: the essential role that the 'we' plays in psychedelic healing and spirituality

Thurs, December 11th 7pm EST / 4pm PST

Speaker Bio: Amy Bartlett is a curiosity enthusiast currently working on her PhD at the University of Ottawa, Canada. Her research explores the role that community plays in psychedelic integration and its impact on spirituality and healing, and her passions include community building, diversity and inclusion in the psychedelic space, harm reduction, and building pathways for safe, accessible and well-supported experiences with psychedelic substances and non-ordinary states of consciousness. She helps coordinate the Ottawa Psychedelic Education Network (OPEN), Ottawa’s local psychedelic society, as well as hosting the “My Psychedelic Roots’ podcast, and has facilitated over 150 free community integration circles. She has a law degree as well as her masters of law, and before returning to school for her PhD, worked for almost 20 years in human rights and social justice causes in Canada and around the world. 

Talk Abstract: “For some, the study of psychedelic integration is still considered to be in its infancy, not just within the broader canon of academic literature, but even within the field of psychedelic studies itself. That said, while there has been a recent explosion of interest and discussion around the topic of psychedelic substances, the practice of integrating those psychedelic experiences has been helping to ground the conversation around these non-ordinary states of consciousness, slowly emerging as a core practice in modern academic discourse on both the spiritual and therapeutic use of psychedelics. Consequently, as the value and impact of psychedelic integration has slowly become more accepted in academic and cultural conversation, our understanding of what it means to ‘integrate’ psychedelic experiences has evolved, and is being broadened to include a wide array of practices and approaches which reflect different cultural traditions, psychological approaches, physical activities, social organizing as well as connecting to traditional and Indigenous wisdom on the use of sacred plant medicines. In terms of the practice itself, by pursuing opportunities to explore, interpret and individually or collectively make meaning of non-ordinary states of consciousness, the practice of integration serves both as a form of harm reduction to minimize post-journey risks associated with psychedelic experiencing, while also crucially providing opportunities to harvest insights and lessons from their psychedelic experience. 

This process of grounding and embodying psychedelic insights can translate into psychological healing, spiritual connection and overall improved wellbeing, all of which can serve a person in their lives and their communities, as well as providing insight for the continued exploration of one’s mind, body and spirit. When it comes to WITH WHOM people are integrating their psychedelic experiences, the research is still in early stages, with much of the current research on psychedelics and healing in this revival era focusing on integration practices in a therapeutic container or framed by a clinical model of care. When it comes to understanding the opportunity that psychedelic holds for individual and collective reflection and understanding, there is much more research needed on the ways that most human beings have been using psychedelics and integrating their psychedelic experiences for millennia: namely, with their peers and in community. Whether within shamanistic traditions and religious communities, or by connecting with others in psychedelic societies and peer support structures, the academic literature is only just beginning to grapple with this under-explored feature of psychedelic integration. This presentation will dive into the foundations of the concept of integration, explore some of the understudied ways that psychedelic integration can be understood, and present new data on the lived experience of hundreds of psychedelic users who practice integration, and who have highlighted the important role of community in their integration practice. 

Learn more at Amy’s Website

November 11, 2025

MAPS Canada presents:

Psychedelics and Veterans: A New Hope with Gordon Hurley

In this episode, MAPS Canada Podcast host Osheen Dayal speaks with Gordon Hurley — a veteran whose story sheds light on how psychedelics and cannabis can support healing after trauma.

Gordon shares how his military experience shaped his risk tolerance and acceptance, and how psychedelic therapy can be a game-changer for mental health. From viewing psychedelics as medicine to exploring the role of creativity, community, and new neural pathways in recovery — this conversation highlights the transformative potential of these therapies.

November 1, 2025

MAPS Canada presents:

Psychedelics & First Responders: Jonathan A Hill on Psychedelics Clinical Trial for First Responders

In this episode of the MAPS Canada Podcast, Osheen Dayal hosts Jonathan Alexander Hill, co-founder of Empower Psychedelics. 🌿🎙️

Jonathan shares the mission behind Empower Psychedelics: advancing research, breaking stigma, and creating access to psychedelic therapy — especially for first responders. He discusses their Health Canada–approved clinical trial focused on firefighters, the unique benefits of group therapy, and the global interest among first responders in psychedelic healing.

This conversation highlights the importance of public education, collaboration with MAPS Canada, and distinguishing clinical practice from underground use. Jonathan also reflects on the future of legalization and how psychedelic access may differ from the cannabis model.

November 20, 2025

MAPS Canada presents:

Psychedelic-Assisted Therapy & Medical Assistance in Dying

Thurs, November 20th 7pm EST / 4pm PST

Join us for a live webinar exploring how psychedelic-assisted therapy can support people who are seeking medical assistance in death. Hear from a panel of individuals with experience and expertise in healthcare, law, research and live-experience about the potential benefits and challenges in providing psychedelic-assisted therapy for people considering MAiD.

Panelists: Dr. Ellen Wiebe Dr. Valorie Masuda Florence Moureau Dr. Houman Farzin Paul Lewin

Host: Kyle Sittek-Lumsden

Learning Objectives:

  • Learn about the current state of laws, policies and regulations surrounding MAiD in Canada.Learn about the current state of laws, policies and regulations surrounding access to PAT for people experiencing end of life distress.
  • Gain an understanding about the history and efficacy of PAT for palliative care and end of life distress.Discover the challenges and barriers that individuals face when applying for legal access to psychedelics while experiencing end of life distress.
  • Explore how the requirements for MAiD provide a potential pathway for legal access to PAT

November 13, 2025

MAPS Canada presents:

Variations in Psychedelic Interventions for Psychological Suffering at the End of Life: Insights from a Scoping Review

Thurs, November 13th 7pm EST / 4pm PST

Sarah Kratina, RN, PhD, is a clinician and researcher specializing in mental health, psychedelic interventions and drug policy. She is currently pursuing her MN-NP at the University of Alberta, and completed her BScN at McMaster University in Hamilton, Ontario, and her PhD at the University of Toronto in the Institute of Health Policy Management and Evaluation. Her research interests focus on the therapeutic potential of psychedelic interventions in various populations, including those with addictions, and individuals experiencing end-of-life distress. Clinically, Sarah works in the field of mental health and addictions. Early-stage research on psychedelic interventions for psychological suffering associated with the end of life is highly diverse. Sociocultural factors shape both the methods, interventional approaches used, and the explanations applied to each substance. Ketamine was mainly linked to the biomedical model, unlike other substances. Outcome measures spanned biopsychosocial-spiritual domains. The therapeutic value of challenging experiences remains uncertain. Exploring treatment diversity is essential, but greater standardisation in reporting would enhance the rigor of future research.

Presentation abstract: Early-stage research on psychedelic interventions for psychological suffering associated with the end of life is highly diverse. Sociocultural factors shape both the methods, interventional approaches used, and the explanations applied to each substance. Ketamine was mainly linked to the biomedical model, unlike other substances. Outcome measures spanned biopsychosocial-spiritual domains. The therapeutic value of challenging experiences remains uncertain. Exploring treatment diversity is essential, but greater standardisation in reporting would enhance the rigor of future research.

October 27, 2025

MAPS Canada presents:

Healing Trauma: New Frontiers for Veterans & First Responders

Mon, October 27th 7pm EST / 4pm PST

Veterans and first responders carry invisible wounds long after their service ends. This webinar explores how psychedelic-assisted therapy is emerging as a powerful tool in treating trauma, PTSD, and moral injury among those who have served on the frontlines. Drawing on current research from Heroic Hearts Canada and lived experience, participants will hear directly from researchers, clinicians, experienced veterans and first responders who have explored this path of healing. Together, we’ll examine how psychedelics have restored connection, supported emotional regulation, and provided meaning. Attendees will also gain insight into the neuroscience of trauma and integration practices that support long-term recovery. Whether you’re a clinician, veteran,  first responder, anyone interested in innovative mental health approaches – this session offers an evidence-based and compassionate look at a new frontier in mental health care.

Learning Objectives: 

  1. Gain a deeper understanding of the emotional and psychological challenges that first responders and veterans face during and after their service.
  2. Learn how psychedelic-assisted therapy and other alternative approaches are helping first responders and veterans heal from trauma and reconnect with purpose.
  3. Hear powerful personal stories of transformation and resilience from individuals who have walked the path from service to healing.
  4. Discover how we can collectively reduce stigma and create safer, more compassionate systems of care for those who dedicate their lives to helping others.

October 30, 2025

MAPS Canada presents:

Psychedelic-assisted group therapy for first responders: A proposal

Thurs, October 30th 7pm EST / 4pm PST

First responders, such as firefighters, often witness traumatic events including death or serious injury. These experiences can lead to depression and post-traumatic stress at rates several times higher than in the general population. A recent Canadian survey found that first responders both report high rates of illicit drug use and generally positive attitudes towards psychedelic-assisted therapy. Few psychedelic trials, however, have focused on this population. In this presentation, we will describe an upcoming trial recently approved by Health Canada. First responders will take part in a 12-week program based on the Gathering Groups protocol, which teaches mindfulness, self-compassion, and emotional processing. At week eight, participants will receive psilocybin at an overnight retreat centre and will undergo the experience in a group setting. At two-week and six-month follow-ups, we will measure the effects on depression, anxiety, and post-traumatic stress compared to a control group. The study will also assess the feasibility and safety of this group protocol. If successful, the results could support a scalable and cost-effective approach to reducing trauma among first responders. Recruitment is planned to begin in 2026.

Dr. Jay Olson is a Postdoctoral Fellow in the Department of Psychology at the University of Toronto. He studies a range of topics across psychology and medicine including psychedelics, placebos, creativity, and smartphone addiction. He did his previous graduate and postdoctoral training at McGill University and Harvard University.

September 27, 2025

MAPS Canada presents:

Exploring Spiritual Care in Psychedelic Therapy with Sinéad, Dr. Blainey & Reverend Jeffrey

Exploring Spiritual Care in Psychedelic Therapy with Sinéad Sullivan-Paul, Dr. Marc Blainey, Reverend Jeffrey Vidt In this episode of the MAPS Canada Podcast, Osheen Dayal hosts a conversation on integrating spiritual care into psychedelic therapy — honouring Indigenous wisdom, navigating ethics in clinical trials, and redefining spirituality in this evolving field. 🌿

Takeaways:

  • Spiritual care is essential in psychedelic therapy.
  • Indigenous knowledge must be respected in psychedelic practices.
  • Clinical ethics should integrate spiritual exploration.
  • Spirituality can be defined in many personal ways. -The Canadian Association for Spiritual Care promotes spiritual competencies.

September 22, 2025

MAPS Canada presents:

Psychedelics & Cross-Cultural Mysticism: Dr. Amod Lele on Philosophy & Self-Transcendence

In this episode, host Osheen sits down with Dr. Amod Sandhya Lele to explore the intersections of psychedelics, mysticism, and comparative philosophy. 

Dr. Lele shares his journey into Buddhism and how it shaped his understanding of mystical experiences—highlighting self-transcendence, cultural influences, and the role of psychedelics in exploring mysticism. 

Check out the podcast to learn more about cross-cultural philosophy, Buddhist thought, and the future of psychedelic mysticism research.

September 18, 2025

MAPS Canada presents:

Pathways of Integration: Transmuting Psychedelic and Other Exceptional Experiences

Thurs, September 18th 7pm EST / 4pm PST

This presentation shares findings from recent research into how experiencers process psychedelic and other exceptional experiences such as NDEs, kundalini and other spiritual awakenings, and UFO/alien encounters. We’ll look at different processing pathways, effective integration strategies, and questions for further research. 

Speaker Bio: Joelle Adams studies the integration and transmutation of psychedelic and other exceptional experiences for improved wellbeing. She is currently completing her PhD in Applied Transpersonal Psychology at the Alef Trust and Liverpool John Moores University in the UK. Joelle completed her BA at Western University in London, Canada and her MA in Professional Practice in Higher Education at Bath Spa University in the UK. She also teaches critical thinking and academic composition at Santa Monica College. Joelle enjoys exploring altered states of consciousness, dancing, black coffee, and sharing life lessons with her teenaged nieces.

 

MAPS Canada's Psychedelic Access CoP Committee presents:

Cannabis and Psychedelics: From Conceptualization to Care in Canada

From shifting laws to evolving therapeutic uses, the line between cannabis and psychedelics is more blurred than ever. This course explores where they align—and where they diverge.

Now open for registration!

Full Course Bundle includes 3 courses:
Course 1: Conceptualizations and Communities
Course 2: Mechanisms of Action, Clinical Research, Therapeutic Applications
Course 3: Legal Landscape and Policy Pathways

February 22, 2025

MAPS Canada Presents:

Cafe Scientifique on Psychedelics and Health Equity

Cafe Scientifique – Psychedelic & Health Equity Dialogue:
MAPS Canada was proud to co-host a CIHR-funded event with over 130 attendees that brought together leading researchers from across Canada including Dr. Erika Dyck, Dr. Monnica Williams, Amy Bartlett and Otis Jasper to explore topics such as:

  • Psychedelic diversity: Lessons from the past with Dr. Erika Dyck – Watch now 

  • A Story of Queerness and Psychedelics  with Amy Bartlett- Watch now

  • How Indigenous Peoples Keep Their Spirituality Alive Amid Ongoing Injustice with Otis Jasper – Watch now 

  • Cafe Scientifique on Psychedelics and Health Equity with Dr. Monnica Williams – Watch now 
 

In addition to the graphic report above, we’ve compiled a full report and recording of the event to share what we learned about the gaps, opportunities, and solutions for health equity in the psychedelic space.

January 13, 2025

MAPS Canada presents:

Catching up with Rick Doblin: FDA's MDMA Decision and What's Next for 2025

Join us online for an exclusive event with Rick Doblin, the founder of MAPS, as we discuss the recent FDA decision on MDMA and what the future holds for 2025. Don’t miss this opportunity to hear firsthand insights from Rick Doblin himself and learn more about the exciting developments in the world of psychedelic research and therapy. Access recording here.

MAPS Canada's SAP CoP Committee presents:

The Special Access Program Tip Sheet

Our SAP Tip Sheet is now live! Learn how you can access Psychedelic-Assisted Therapy (PAT) through Health Canada’s SAP program. You can find tips and templates to streamline your application process!

Disclaimer: The content in this document provides general educational information about regulatory pathways and does not advertise, promote, or recommend any drug, therapy, or medical intervention. It should not be used to diagnose, treat, or guide individual patient care. All decisions regarding treatment or access pathways must be made by licensed   prescribers in the context of a patient care relationship. This document mentions health products the safety and effectiveness of which are still under investigation and that Health Canada has not yet granted market authorization in respect of. This document is an independent initiative of MAPS Canada and should not be interpreted as approved, reviewed by or endorsed by Health Canada.

MAPS Canada's School of Psychedelics presents:

Psychedelics in Canada: Past, Present and Future

Experience the full spectrum of psychedelic knowledge with our complete seminar series. These seven insightful courses cover everything from the historical roots to the modern applications of psychedelics.

BALANCING SAFETY AND ACCESS REPORT

Please read our report on Alberta’s Regulations and service standards, and related recommendations.

MAPS Canada is powered by a large and dedicated group of volunteers!